Financial News
Scinai Immunotherapeutics Ltd ADR (NQ: SCNI )
2.780
-0.080
(-2.80%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Jun 28, 2024
Add to My Watchlist
Press Releases about Scinai Immunotherapeutics Ltd ADR
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
November 03, 2023
Via GlobeNewswire
Potential Complications of Untreated Psoriasis
November 02, 2023
Why Food Allergy Prevalence Is Growing
September 13, 2023
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Study Identifies Immune Cells Responsible for Severe Asthma
October 30, 2023
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
October 30, 2023
Via GlobeNewswire
Five Ways to Treat Infectious Diseases While Keeping Antimicrobial Resistance in Check
October 23, 2023
Exposures
COVID-19
Syndromic Testing Could Transform Infectious Disease Diagnosis
October 11, 2023
Exposures
COVID-19
Researchers Find Psoriasis Increases Risk of Heart Disease
October 05, 2023
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Inverse Vaccines Show Promise Against Autoimmunity
September 25, 2023
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Study Shows Climate Change Impacts Infectious Disease Risks
September 19, 2023
Topics
Climate Change
Exposures
Climate
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
September 15, 2023
Via GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study
September 14, 2023
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.